EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S — Credit Rating and Financial Key Figures
CVR number: 29428689
Smedeskovvej 38, 8464 Galten
Income statement (kDKK)
2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 38 294.00 | 41 728.00 | 51 639.00 | 56 377.97 | 65 198.99 |
| Employee benefit expenses | -39 094.34 | -50 340.51 | |||
| Total depreciation | -2 397.82 | -2 217.27 | |||
| EBIT | 6 712.00 | 9 533.00 | 13 184.00 | 14 885.81 | 12 641.22 |
| Other financial income | 303.16 | 483.15 | |||
| Other financial expenses | - 358.09 | - 924.39 | |||
| Pre-tax profit | 5 033.00 | 7 248.00 | 9 757.00 | 14 830.88 | 12 199.97 |
| Income taxes | -3 276.15 | -2 688.09 | |||
| Net earnings | 5 033.00 | 7 248.00 | 9 757.00 | 11 554.73 | 9 511.88 |
Assets (kDKK)
2021 | 2022 | |
|---|---|---|
| Development expenditure | 73.41 | |
| Intangible rights | 642.85 | 600.64 |
| Intangible assets total | 642.85 | 674.05 |
| Buildings | 3 055.56 | 1 380.37 |
| Machinery and equipment | 4 295.65 | 3 071.57 |
| Advance payments and construction in progress | 17 985.14 | |
| Other tangible assets | 0.00 | |
| Tangible assets total | 7 351.22 | 22 437.07 |
| Other non-current investments | -0.00 | |
| Investments total | 1 256.80 | 1 256.80 |
| Long term receivables total | ||
| Raw materials and consumables | 496.96 | 550.80 |
| Inventories total | 496.96 | 550.80 |
| Current trade debtors | 13 411.02 | 15 261.79 |
| Current amounts owed by group member comp. | 23 342.86 | 18 196.94 |
| Prepayments and accrued income | 63.37 | 678.81 |
| Current other receivables | 2 651.96 | 1 504.04 |
| Current deferred tax assets | 93.21 | 302.74 |
| Short term receivables total | 39 562.41 | 35 944.32 |
| Cash and bank deposits | 1.39 | |
| Cash and cash equivalents | 1.39 | |
| Balance sheet total (assets) | 49 311.63 | 60 863.04 |
Equity and liabilities (kDKK)
2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Share capital | 7 989.00 | 10 237.00 | 12 994.00 | 700.00 | 700.00 |
| Shares repurchased | 10 000.00 | 9 500.00 | |||
| Retained earnings | -5 033.00 | -7 248.00 | -9 757.00 | -3 705.77 | -1 651.04 |
| Profit of the financial year | 5 033.00 | 7 248.00 | 9 757.00 | 11 554.73 | 9 511.88 |
| Shareholders equity total | 7 989.00 | 10 237.00 | 12 994.00 | 18 548.96 | 18 060.84 |
| Non-current owed to group member | 6 021.19 | 13 021.19 | |||
| Non-current deferred tax liabilities | 3 256.64 | 3 256.64 | |||
| Non-current liabilities total | 9 277.83 | 16 277.83 | |||
| Current loans from credit institutions | 29.34 | 26.71 | |||
| Current trade creditors | 4 749.11 | 10 033.53 | |||
| Current owed to group member | 4 094.16 | 2 588.25 | |||
| Short-term deferred tax liabilities | 708.83 | 1 486.47 | |||
| Other non-interest bearing current liabilities | 11 903.41 | 12 389.41 | |||
| Current liabilities total | 21 484.85 | 26 524.38 | |||
| Balance sheet total (liabilities) | 7 989.00 | 10 237.00 | 12 994.00 | 49 311.63 | 60 863.04 |
CreditReports API
- Company information
- Financial data
- Credit risk data
- All 400,000+ Danish companies
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.